Background. Patients with cirrhosis have a high risk of hepatocellular carcinoma (HCC) but it is unclear how the etiology of liver disease influences tumor development. The authors evaluated hepatitis B and C virus (HBV, HCV) infection in cirrhosis in relation to the risk of HCC. Methods. Two hundr
Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients
β Scribed by Susumu Takano; Osamu Yokosuka; Fumio Imazeki; Masami Tagawa; Masao Omata
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 655 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
The incidence of hepatocellular carcinoma (HCC) was prospectively studied in 251 chronic hepatitis patients, and was compared between the 127 cases of hepatitis B and 124 cases of hepatitis C. All patients were diagnosed by needle biopsy on entering the study, and the cases consisted of chronic persistent hepatitis (CPH), chronic active hepatitis (CAH)2a, and CAH!2b (cirrhosis was not included). Of the cases of chronic hepatitis B, 5 cases of HCC (3.%) were detected; among the chronic hepatitis C cases, 13 cases (10.4%) were detected. Thus, although the mean follow-up periods were in the same range, the incidence of hepatocellular carcinoma was 2.7 times higher in hepatitis C than in hepatitis B (xz = 3.116, P < .05). Using the Kaplan-Meier method, the incidence of HCC was significantly higher in chronic hepatitis C ( P = .0194, generalized Wilcoxon test). In hepatitis C, the incubation period until HCC was detected was shorter when the liver disease was more advanced. Such a tendency was not observed in hepatitis B. In the 13 cases of HCC occurring in chronic hepatitis C, noncirrhotic liver was seen in only 1 case (7.7%), whereas 2 of the 5 cases of HCC (40%) in chronic hepatitis B were noncirrhotic. The prevalence of hepatitis C virus (HCV) genotypes I1 and I11 was the same in the total followed cases and HCC cases. (HEPATOLOGY 1995;21:650-655.)
The incidence of hepatocellular carcinoma (HCC) has been increasing in Japan over the last 30 years.' The major risk factors for HCC are reported to be the carrier state of hepatitis B virus (HBV),223 food contamination by a f l a t ~x i n , ~' ~ and cirrhosis of the On a worldwide scale, the incidence of HCC in Japan is thought to be approximately in the middle, and most HCCs in this country are accompanied by c i r r h o s i ~. ~~~~
The main reason for the noted increase of HCC might be the longer survival of patients with cirrhosis and chronic Abbreviations: HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; CAH, chronic active hepatitis; HBsAg, HBV surface antigen.
π SIMILAR VOLUMES
approximately 3%. 3,4 Early detection of HCC in cirrhotic pa-A prospective study was performed to establish tients can usually be achieved by screening with noninvasive whether infection with specific hepatitis C virus (HCV) techniques, such as ultrasound (US) scan and serum a-fetogenotypes was ass
## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa
Objective: To prospectively determine the prevalence and annual incidence of hepatocellular carcinoma in hepatitis B carriers in a heterogeneous urban North American population and to assess the diagnostic accuracy of tests used for screening for this cancer. Design: Prospective cohort study of 1,06
## Abstract Interferon treatment for chronic hepatitis C reduces the incidence of hepatocellular carcinoma (HCC) in sustained responders. However, estimation of the effect of interferon treatment on HCC development in nonresponders is yet to be fully implemented. We conducted a metaβanalysis of 3 r